Sofinnova Investments’s Exelixis EXEL Stock Holding History

Sofinnova Investments’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,300	Closed	-$206K	–	62
2018 Q1	$206K	Buy	+9,300	New	+$257K	0.04%	46

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Sofinnova Investments's EXEL Position: Q4 2023 in Review

Sofinnova Investments sold out of Exelixis (EXEL) in Q4 2023, closing a stake of 830,764 shares — an estimated $18.2M sold.

Sofinnova Investments first reported a position in EXEL in Q3 2018 and held it in 7 quarters. The position peaked at $48.9M in Q2 2023. 425 funds tracked by Wall St. Rank hold EXEL as of Q4 2023.

Sofinnova Investments reported no remaining Exelixis position as of Q4 2023 after selling out during the quarter.
Sofinnova Investments sold 830,764 Exelixis shares in Q4 2023, an estimated $18.2M.
Sofinnova Investments first reported a position in Exelixis in Q3 2018 and held it in 7 quarters.
Sofinnova Investments's Exelixis position peaked at $48.9M in Q2 2023.
425 funds tracked by Wall St. Rank held Exelixis as of Q4 2023.

Based on Sofinnova Investments's 13F filing for Q4 2023, filed 13 Feb 2024.